Bio-Rad Laboratories, Inc. (BIO)
USD 249.62
(1.55%)
USD 249.62
(1.55%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 780.51 Million USD | 8.51% |
| 2022 | 719.31 Million USD | 25.7% |
| 2021 | 572.23 Million USD | -8.04% |
| 2020 | 622.25 Million USD | 12.32% |
| 2019 | 554 Million USD | -5.19% |
| 2018 | 584.33 Million USD | -1.76% |
| 2017 | 594.8 Million USD | 13.3% |
| 2016 | 524.96 Million USD | 7.09% |
| 2015 | 490.22 Million USD | 4.08% |
| 2014 | 470.99 Million USD | -6.04% |
| 2013 | 501.29 Million USD | 11.8% |
| 2012 | 448.37 Million USD | 3.43% |
| 2011 | 433.51 Million USD | 8.89% |
| 2010 | 398.1 Million USD | 13.35% |
| 2009 | 351.2 Million USD | -6.5% |
| 2008 | 375.61 Million USD | 17.01% |
| 2007 | 321.01 Million USD | 26.86% |
| 2006 | 253.04 Million USD | 19.17% |
| 2005 | 212.34 Million USD | 3.32% |
| 2004 | 205.51 Million USD | 8.02% |
| 2003 | 190.25 Million USD | 14.36% |
| 2002 | 166.37 Million USD | 19.54% |
| 2001 | 139.17 Million USD | 5.03% |
| 2000 | 132.51 Million USD | 4.92% |
| 1999 | 126.3 Million USD | 36.69% |
| 1998 | 92.4 Million USD | 1.09% |
| 1997 | 91.4 Million USD | 31.13% |
| 1996 | 69.7 Million USD | -7.56% |
| 1995 | 75.4 Million USD | 2.86% |
| 1994 | 73.3 Million USD | 1.66% |
| 1993 | 72.1 Million USD | -12.5% |
| 1992 | 82.4 Million USD | 14.29% |
| 1991 | 72.1 Million USD | 14.08% |
| 1990 | 63.2 Million USD | 18.8% |
| 1989 | 53.2 Million USD | 20.36% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 803.69 Million USD | 2.59% |
| 2024 Q3 | 804.27 Million USD | 0.07% |
| 2024 Q1 | 783.36 Million USD | 0.37% |
| 2023 Q1 | 752.93 Million USD | 4.67% |
| 2023 Q4 | 780.51 Million USD | 0.61% |
| 2023 FY | 780.51 Million USD | 8.51% |
| 2023 Q3 | 775.81 Million USD | -0.1% |
| 2023 Q2 | 776.6 Million USD | 3.14% |
| 2022 Q4 | 719.31 Million USD | 4.88% |
| 2022 Q3 | 685.85 Million USD | 4.37% |
| 2022 Q2 | 657.13 Million USD | 8.53% |
| 2022 Q1 | 605.49 Million USD | 5.81% |
| 2022 FY | 719.31 Million USD | 25.7% |
| 2021 Q4 | 572.23 Million USD | -2.83% |
| 2021 FY | 572.23 Million USD | -8.04% |
| 2021 Q3 | 588.91 Million USD | -1.68% |
| 2021 Q2 | 598.98 Million USD | -1.02% |
| 2021 Q1 | 605.15 Million USD | -2.75% |
| 2020 FY | 622.25 Million USD | 12.32% |
| 2020 Q1 | 557.02 Million USD | 0.55% |
| 2020 Q2 | 628.4 Million USD | 12.81% |
| 2020 Q3 | 640.22 Million USD | 1.88% |
| 2020 Q4 | 622.25 Million USD | -2.81% |
| 2019 Q3 | 587.98 Million USD | -0.32% |
| 2019 Q4 | 554 Million USD | -5.78% |
| 2019 Q2 | 589.89 Million USD | -0.09% |
| 2019 FY | 554 Million USD | -5.19% |
| 2019 Q1 | 590.43 Million USD | 1.04% |
| 2018 FY | 584.33 Million USD | -1.76% |
| 2018 Q4 | 584.33 Million USD | -2.78% |
| 2018 Q3 | 601.05 Million USD | 1.63% |
| 2018 Q2 | 591.43 Million USD | -3.39% |
| 2018 Q1 | 612.21 Million USD | 2.93% |
| 2017 FY | 594.8 Million USD | 13.3% |
| 2017 Q4 | 594.8 Million USD | -1.12% |
| 2017 Q3 | 601.57 Million USD | 3.62% |
| 2017 Q2 | 580.58 Million USD | 3.71% |
| 2017 Q1 | 559.81 Million USD | 6.64% |
| 2016 FY | 524.96 Million USD | 7.09% |
| 2016 Q3 | 556.35 Million USD | 2.74% |
| 2016 Q4 | 524.96 Million USD | -5.64% |
| 2016 Q2 | 541.51 Million USD | 1.54% |
| 2016 Q1 | 533.31 Million USD | 8.79% |
| 2015 Q2 | 500.97 Million USD | 4.72% |
| 2015 Q3 | 512.73 Million USD | 2.35% |
| 2015 FY | 490.22 Million USD | 4.08% |
| 2015 Q1 | 478.37 Million USD | 1.57% |
| 2015 Q4 | 490.22 Million USD | -4.39% |
| 2014 Q1 | 513.85 Million USD | 2.51% |
| 2014 Q3 | 516.04 Million USD | -0.88% |
| 2014 Q2 | 520.64 Million USD | 1.32% |
| 2014 FY | 470.99 Million USD | -6.04% |
| 2014 Q4 | 470.99 Million USD | -8.73% |
| 2013 Q2 | 484.66 Million USD | 3.71% |
| 2013 Q4 | 501.29 Million USD | -4.24% |
| 2013 Q3 | 523.5 Million USD | 8.01% |
| 2013 Q1 | 467.32 Million USD | 4.23% |
| 2013 FY | 501.29 Million USD | 11.8% |
| 2012 FY | 448.37 Million USD | 3.43% |
| 2012 Q1 | 463.36 Million USD | 6.89% |
| 2012 Q2 | 449.45 Million USD | -3.0% |
| 2012 Q3 | 458.42 Million USD | 2.0% |
| 2012 Q4 | 448.37 Million USD | -2.19% |
| 2011 Q1 | 429.97 Million USD | 8.01% |
| 2011 Q2 | 449.33 Million USD | 4.5% |
| 2011 Q3 | 445.58 Million USD | -0.84% |
| 2011 Q4 | 433.51 Million USD | -2.71% |
| 2011 FY | 433.51 Million USD | 8.89% |
| 2010 Q1 | 380.7 Million USD | 8.4% |
| 2010 FY | 398.1 Million USD | 13.35% |
| 2010 Q4 | 398.1 Million USD | -1.19% |
| 2010 Q3 | 402.88 Million USD | 8.81% |
| 2010 Q2 | 370.27 Million USD | -2.74% |
| 2009 Q2 | 377.59 Million USD | 2.32% |
| 2009 FY | 351.2 Million USD | -6.5% |
| 2009 Q1 | 369.04 Million USD | -1.75% |
| 2009 Q4 | 351.2 Million USD | -8.52% |
| 2009 Q3 | 383.89 Million USD | 1.67% |
| 2008 Q4 | 375.61 Million USD | -2.0% |
| 2008 Q2 | 382.68 Million USD | 4.83% |
| 2008 Q1 | 365.05 Million USD | 13.72% |
| 2008 FY | 375.61 Million USD | 17.01% |
| 2008 Q3 | 383.26 Million USD | 0.15% |
| 2007 Q3 | 273.57 Million USD | 3.16% |
| 2007 Q4 | 321.01 Million USD | 17.34% |
| 2007 Q1 | 259.96 Million USD | 2.73% |
| 2007 FY | 321.01 Million USD | 26.86% |
| 2007 Q2 | 265.18 Million USD | 2.01% |
| 2006 Q1 | 225.84 Million USD | 6.36% |
| 2006 FY | 253.04 Million USD | 19.17% |
| 2006 Q2 | 244.33 Million USD | 8.19% |
| 2006 Q3 | 246.2 Million USD | 0.76% |
| 2006 Q4 | 253.04 Million USD | 2.78% |
| 2005 Q2 | 211.52 Million USD | 1.25% |
| 2005 Q3 | 223.14 Million USD | 5.49% |
| 2005 Q4 | 212.34 Million USD | -4.84% |
| 2005 FY | 212.34 Million USD | 3.32% |
| 2005 Q1 | 208.92 Million USD | 1.66% |
| 2004 Q2 | 188.56 Million USD | -0.77% |
| 2004 Q4 | 205.51 Million USD | 2.66% |
| 2004 FY | 205.51 Million USD | 8.02% |
| 2004 Q1 | 190.03 Million USD | -0.12% |
| 2004 Q3 | 200.18 Million USD | 6.16% |
| 2003 Q3 | 189.18 Million USD | 1.56% |
| 2003 FY | 190.25 Million USD | 14.36% |
| 2003 Q1 | 172.91 Million USD | 3.93% |
| 2003 Q2 | 186.27 Million USD | 7.73% |
| 2003 Q4 | 190.25 Million USD | 0.57% |
| 2002 FY | 166.37 Million USD | 19.54% |
| 2002 Q3 | 160.68 Million USD | 3.81% |
| 2002 Q4 | 166.37 Million USD | 3.54% |
| 2002 Q1 | 141.66 Million USD | 1.79% |
| 2002 Q2 | 154.77 Million USD | 9.26% |
| 2001 FY | 139.17 Million USD | 5.03% |
| 2001 Q4 | 139.17 Million USD | -12.44% |
| 2001 Q3 | 158.94 Million USD | 11.71% |
| 2001 Q2 | 142.28 Million USD | 4.08% |
| 2001 Q1 | 136.71 Million USD | 3.16% |
| 2000 Q3 | 124.81 Million USD | -10.42% |
| 2000 Q4 | 132.51 Million USD | 6.17% |
| 2000 FY | 132.51 Million USD | 4.92% |
| 2000 Q1 | 136.28 Million USD | 7.91% |
| 2000 Q2 | 139.32 Million USD | 2.23% |
| 1999 Q1 | 91.7 Million USD | -0.76% |
| 1999 Q3 | 96.4 Million USD | 5.13% |
| 1999 Q4 | 126.3 Million USD | 31.02% |
| 1999 Q2 | 91.7 Million USD | 0.0% |
| 1999 FY | 126.3 Million USD | 36.69% |
| 1998 Q2 | 93.4 Million USD | -0.74% |
| 1998 Q4 | 92.4 Million USD | -4.64% |
| 1998 FY | 92.4 Million USD | 1.09% |
| 1998 Q1 | 94.1 Million USD | 2.95% |
| 1998 Q3 | 96.9 Million USD | 3.75% |
| 1997 Q4 | 91.4 Million USD | 10.92% |
| 1997 Q1 | 73.1 Million USD | 4.88% |
| 1997 Q2 | 77.3 Million USD | 5.75% |
| 1997 Q3 | 82.4 Million USD | 6.6% |
| 1997 FY | 91.4 Million USD | 31.13% |
| 1996 Q1 | 72.5 Million USD | -3.85% |
| 1996 Q2 | 72.6 Million USD | 0.14% |
| 1996 Q3 | 74.1 Million USD | 2.07% |
| 1996 Q4 | 69.7 Million USD | -5.94% |
| 1996 FY | 69.7 Million USD | -7.56% |
| 1995 FY | 75.4 Million USD | 2.86% |
| 1995 Q1 | 80.4 Million USD | 9.69% |
| 1995 Q2 | 85.4 Million USD | 6.22% |
| 1995 Q3 | 83.9 Million USD | -1.76% |
| 1995 Q4 | 75.4 Million USD | -10.13% |
| 1994 Q2 | 72.8 Million USD | 2.54% |
| 1994 Q4 | 73.3 Million USD | -1.48% |
| 1994 FY | 73.3 Million USD | 1.66% |
| 1994 Q1 | 71 Million USD | -1.53% |
| 1994 Q3 | 74.4 Million USD | 2.2% |
| 1993 Q1 | 86 Million USD | 4.37% |
| 1993 Q2 | 85.5 Million USD | -0.58% |
| 1993 Q3 | 83.9 Million USD | -1.87% |
| 1993 Q4 | 72.1 Million USD | -14.06% |
| 1993 FY | 72.1 Million USD | -12.5% |
| 1992 Q4 | 82.4 Million USD | -7.42% |
| 1992 FY | 82.4 Million USD | 14.29% |
| 1992 Q1 | 76.6 Million USD | 6.24% |
| 1992 Q2 | 83.7 Million USD | 9.27% |
| 1992 Q3 | 89 Million USD | 6.33% |
| 1991 Q4 | 72.1 Million USD | 2.85% |
| 1991 Q1 | 65.6 Million USD | 3.8% |
| 1991 Q2 | 66.6 Million USD | 1.52% |
| 1991 Q3 | 70.1 Million USD | 5.26% |
| 1991 FY | 72.1 Million USD | 14.08% |
| 1990 FY | 63.2 Million USD | 18.8% |
| 1990 Q2 | 59.5 Million USD | 6.06% |
| 1990 Q3 | 62.6 Million USD | 5.21% |
| 1990 Q4 | 63.2 Million USD | 0.96% |
| 1990 Q1 | 56.1 Million USD | 5.45% |
| 1989 FY | 53.2 Million USD | 20.36% |
| 1989 Q4 | 53.2 Million USD | -0.93% |
| 1989 Q3 | 53.7 Million USD | 2.68% |
| 1989 Q2 | 52.3 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 88.12% |
| Allurion Technologies Inc. | 6.17 Million USD | -12548.145% |
| Artivion, Inc. | 81.97 Million USD | -852.129% |
| Avanos Medical, Inc. | 163.2 Million USD | -378.258% |
| Butterfly Network, Inc. | 75.83 Million USD | -929.203% |
| Butterfly Network, Inc. | 75.83 Million USD | -929.203% |
| Boston Scientific Corporation | 2.48 Billion USD | 68.578% |
| CONMED Corporation | 318.32 Million USD | -145.196% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 33.186% |
| Paragon 28, Inc. | 98.06 Million USD | -695.942% |
| Glaukos Corporation | 41.98 Million USD | -1758.993% |
| Globus Medical, Inc. | 848.13 Million USD | 7.973% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | -2203.429% |
| Integer Holdings Corporation | 239.71 Million USD | -225.601% |
| Medtronic plc | 5.21 Billion USD | 85.039% |
| Myomo, Inc. | 1.8 Million USD | -43177.736% |
| Nevro Corp. | 118.67 Million USD | -557.687% |
| Owlet, Inc. | 6.49 Million USD | -11920.899% |
| Penumbra, Inc. | 388.02 Million USD | -101.152% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 67.411% |
| Sonendo, Inc. | 11.07 Million USD | -6948.194% |
| STERIS plc | 674.53 Million USD | -15.712% |
| Stryker Corporation | 4.84 Billion USD | 83.884% |
| Vapotherm, Inc. | 22.96 Million USD | -3298.28% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 67.277% |